GTEX-13NZ9
|
51-60
|
Male
|
GTEX-13NZ9-1326 |
Liver
|
PAXgene |
1
|
2 pieces, micro (mainly) and macrovesicular steatosis involves ~70% parenchyma
|
Acceptable
|
|
GTEX-13NZA
|
61-70
|
Male
|
GTEX-13NZA-1626 |
Liver
|
PAXgene |
1
|
2 pieces, multiple von Meyenberg complexes up to 2.4mm; portal tracts expanded with fibrosis, bile duct proliferation, and chronic inflammation
|
Acceptable
|
|
GTEX-13NZB
|
21-40
|
Male
|
GTEX-13NZB-0626 |
Liver
|
PAXgene |
1
|
2 pieces; congestion
|
Acceptable
|
|
GTEX-13O1R
|
61-70
|
Male
|
GTEX-13O1R-2026 |
Liver
|
PAXgene |
1
|
2 pieces; <5% macrovesicular steatosis
|
Acceptable
|
|
GTEX-13O3O
|
61-70
|
Female
|
GTEX-13O3O-1826 |
Liver
|
PAXgene |
2
|
2 fragmented pieces; 20% of each consists of large vessels & nerves [outlined]
|
Acceptable
|
|
GTEX-13O3P
|
51-60
|
Male
|
GTEX-13O3P-1726 |
Liver
|
PAXgene |
1
|
2 pieces; nodular cirrhosis
|
Acceptable
|
|
GTEX-13O3Q
|
51-60
|
Male
|
GTEX-13O3Q-1026 |
Liver
|
PAXgene |
1
|
2 pieces; <5% macrovesicular steatosis; no active or chronic lesions
|
Acceptable
|
|
GTEX-13OVH
|
61-70
|
Male
|
GTEX-13OVH-0926 |
Liver
|
PAXgene |
1
|
2 pieces, ~5% macrovesicular steatosis
|
Acceptable
|
|
GTEX-13OVJ
|
51-60
|
Female
|
GTEX-13OVJ-1026 |
Liver
|
PAXgene |
1
|
2 pieces; cirrhosis, steatosis, Mallory hyaline c/w alcoholic cirrhosis
|
Acceptable
|
|
GTEX-13OVL
|
41-50
|
Male
|
GTEX-13OVL-0726 |
Liver
|
PAXgene |
1
|
2 fragmented pieces; 5% macrovesicular steatosis
|
Acceptable
|
|
GTEX-13OW5
|
61-70
|
Male
|
GTEX-13OW5-1226 |
Liver
|
PAXgene |
1
|
2 pieces, chronic steatohepatitis, macrovesicular steatosis is ~30% parenchyma; patchy early bridging fibrosis
|
Acceptable
|
|
GTEX-13OW6
|
51-60
|
Male
|
GTEX-13OW6-2626 |
Liver
|
PAXgene |
2
|
2 pieces; congestion and accentuation of portal triads
|
Acceptable
|
|
GTEX-13OW7
|
51-60
|
Male
|
GTEX-13OW7-1326 |
Liver
|
PAXgene |
1
|
2 pieces, diffuse mixed macro/micro vesicular steatosis
|
Acceptable
|
|
GTEX-13OW8
|
61-70
|
Male
|
GTEX-13OW8-0726 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, mild steatosis
|
Acceptable
|
|
GTEX-13PDP
|
61-70
|
Male
|
GTEX-13PDP-1826 |
Liver
|
PAXgene |
2
|
2 pieces; congested
|
Acceptable
|
|
GTEX-13PL6
|
41-50
|
Female
|
GTEX-13PL6-1226 |
Liver
|
PAXgene |
1
|
2 pieces, mild congestion, minimal steatosis
|
Acceptable
|
|
GTEX-13PLJ
|
51-60
|
Female
|
GTEX-13PLJ-1026 |
Liver
|
PAXgene |
2
|
2 pieces; severe fibrosis without nodule formation consistent with cardiac cirrhosis, possible venous outflow obstruction
|
Acceptable
|
|
GTEX-13PVQ
|
51-60
|
Male
|
GTEX-13PVQ-1526 |
Liver
|
PAXgene |
1
|
2 pieces; thick fibrous trabeculae
|
Acceptable
|
|
GTEX-13PVR
|
61-70
|
Female
|
GTEX-13PVR-0126 |
Liver
|
PAXgene |
1
|
2 pieces, minimal steatosis, mulitple bile duct hamartomata (Meyenberg Complex) noted.
|
Acceptable
|
|
GTEX-13QIC
|
61-70
|
Female
|
GTEX-13QIC-0526 |
Liver
|
PAXgene |
1
|
2 pieces; congestion, focal portal chronic inflammation
|
Acceptable
|
|
GTEX-13QJ3
|
51-60
|
Male
|
GTEX-13QJ3-2026 |
Liver
|
PAXgene |
1
|
2 pieces mild macrovesicular steatosis (10-20%)
|
Acceptable
|
|
GTEX-13QJC
|
61-70
|
Female
|
GTEX-13QJC-0726 |
Liver
|
PAXgene |
2
|
2 pieces
|
Acceptable
|
|
GTEX-13RTJ
|
51-60
|
Male
|
GTEX-13RTJ-1226 |
Liver
|
PAXgene |
1
|
2 pieces, severe difffuse passive congestion, mild macrovesicular steatosis
|
Acceptable
|
|
GTEX-13S7M
|
61-70
|
Female
|
GTEX-13S7M-1126 |
Liver
|
PAXgene |
1
|
2 pieces; congested with focal hemorrhages; large vessels comprise 10%; no fat, no cirrhosis
|
Acceptable
|
|
GTEX-13SLW
|
61-70
|
Male
|
GTEX-13SLW-1426 |
Liver
|
PAXgene |
1
|
2 pieces, established cirrhosis, diffuse steatohepatitis, mixed pattern
|
Acceptable
|
|